A novel series of orally active antiplatelet agents
- 31 May 1995
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 3 (5) , 539-551
- https://doi.org/10.1016/0968-0896(95)00045-i
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptorJournal of Medicinal Chemistry, 1993
- Chapter 9. Glycoprotein IIb IIIa AntagonistsPublished by Elsevier ,1993
- Structural studies of potent constrained RGD peptidesJournal of the American Chemical Society, 1992
- Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitorsJournal of Medicinal Chemistry, 1992
- Low molecular weight, non-peptide fibrinogen receptor antagonistsJournal of Medicinal Chemistry, 1992
- Design and synthesis of a C7 mimetic for the predicted .gamma.-turn conformation found in several constrained RGD antagonistsJournal of Medicinal Chemistry, 1992
- Cyclic RGD peptide analogs as antiplatelet antithromboticsJournal of Medicinal Chemistry, 1992
- Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitroJournal of Medicinal Chemistry, 1991
- Lysis of plasminogen activator-resistant platelet-rich coronary artery thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GPIIb/IIIa antibodyJournal of the American College of Cardiology, 1990
- New Perspectives in Cell Adhesion: RGD and IntegrinsScience, 1987